Emphysema -
CONTINUED ACCESS TREATMENT PROTOCOL WITH IBV® VALVE SYSTEM FOR SEVERE EMPHYSEMA (Device: IBV® Valve System, Protocol #CPR-02405)
(2_20080616_118)
This study is for participants previously enrolled in the IBV® Valve Trial (CPR-01377) that did not receive the valve. This study population has completed the requirements of the previous study including the 6 month visit. Participants will receive the IBV® Valve and will be followed for the 6-month period after treatments with the IBV® Valve System for the purpose of collecting safety information on adverse events in this patient population. There will be follow-up visits at one, three and six months.
